Francisella tularensis vaccines

Area of Science:

• Bacteriology and immunology
• Vaccine development
• Biodefense

Background:

• Francisella tularensis is the bacterium responsible for tularaemia, a zoonotic disease.
• The potential use of F. tularensis as a bioterrorism agent has increased interest in developing effective vaccines.
• The live vaccine strain (LVS) of F. tularensis has shown efficacy in human trials but faces licensing challenges.

Purpose of the Study:

• To review the prospects for developing a licensable vaccine against tularaemia.
• To identify the most promising strategies for a new tularaemia vaccine.

Main Methods:

• Review of existing literature on F. tularensis vaccines.
• Evaluation of different vaccine approaches, including killed whole-cell and subunit vaccines.
• Assessment of rationally attenuated mutants as potential vaccine candidates.

Main Results:

• The live vaccine strain (LVS) is effective but unlikely to be licensed.
• Killed whole-cell and subunit vaccines have limitations.
• Rationally attenuated mutants present a viable strategy for a new vaccine.

Conclusions:

• A rationally attenuated mutant of F. tularensis is the most likely candidate for a new, licensable tularaemia vaccine.
• Further research into attenuated mutants is warranted for biodefense applications.